[HTML][HTML] Multifaceted neuroprotective effects of (-)-epigallocatechin-3-gallate (EGCG) in Alzheimer's disease: An overview of pre-clinical studies focused on β-amyloid …
Alzheimer's disease (AD) is the most common neurodegenerative disease characterized by
cognitive decline and memory impairment. Many lines of evidence indicate that excessive β …
cognitive decline and memory impairment. Many lines of evidence indicate that excessive β …
[HTML][HTML] Exploring the therapeutic potential of phytochemicals in Alzheimer's disease: Focus on polyphenols and monoterpenes
I Piccialli, V Tedeschi, L Caputo, S D'Errico… - Frontiers in …, 2022 - frontiersin.org
Alzheimer's disease (AD) is a chronic, complex neurodegenerative disorder mainly
characterized by the irreversible loss of memory and cognitive functions. Different …
characterized by the irreversible loss of memory and cognitive functions. Different …
Modulation of amyloid protein fibrillation by synthetic polymers: Recent advances in the context of neurodegenerative diseases
Protein misfolding and aggregation have attracted immense research interests due to their
connection with an array of degenerative diseases including neurodegenerative disorders …
connection with an array of degenerative diseases including neurodegenerative disorders …
Molecular mechanisms of resveratrol and EGCG in the inhibition of Aβ 42 aggregation and disruption of Aβ 42 protofibril: Similarities and differences
The aggregation of amyloid-β protein (Aβ) into fibrillary deposits is implicated in Alzheimer's
disease (AD), and inhibiting Aβ aggregation and clearing Aβ fibrils are considered as …
disease (AD), and inhibiting Aβ aggregation and clearing Aβ fibrils are considered as …
Current strategies of detecting Aβ species and inhibiting Aβ aggregation: Status and prospects
J Li, W Liao, D Huang, M Ou, T Chen, X Wang… - Coordination Chemistry …, 2023 - Elsevier
Alzheimer's disease (AD) is a central neurodegenerative disorder characterized by
behavioral disturbance and progressive cognitive impairment, and it is common in pre …
behavioral disturbance and progressive cognitive impairment, and it is common in pre …
A comprehensive insight into the mechanisms of dopamine in disrupting Aβ protofibrils and inhibiting Aβ aggregation
Fibrillary aggregates of amyloid-β (Aβ) are the pathological hallmark of Alzheimer's disease
(AD). Clearing Aβ deposition or inhibiting Aβ aggregation is a promising approach to treat …
(AD). Clearing Aβ deposition or inhibiting Aβ aggregation is a promising approach to treat …
Molecular insights into the inhibition of early stages of Aβ peptide aggregation and destabilization of Alzheimer's Aβ protofibril by dipeptide D-Trp-Aib: A molecular …
Amyloid beta (Aβ) peptide aggregates rapidly into the soluble oligomers, protofibrils and
fibrils to form senile plaques, a neurotoxic component and pathological hallmark of …
fibrils to form senile plaques, a neurotoxic component and pathological hallmark of …
Baicalein exhibits differential effects and mechanisms towards disruption of α-synuclein fibrils with different polymorphs
Parkinson's disease (PD) is the second most common neurodegenerative diseases with no
cure yet and its major hallmark is α-synuclein fibrillary aggregates. The crucial role of α …
cure yet and its major hallmark is α-synuclein fibrillary aggregates. The crucial role of α …
[HTML][HTML] Effect of tea polyphenols on the prevention of neurodegenerative diseases through gut microbiota
L Xu, R Wang, Y Liu, S Zhan, Z Wu, X Zhang - Journal of Functional Foods, 2023 - Elsevier
Tea polyphenols (TPs) have shown several memory-enhancing activities. The gut
microbiota is essential in developing neurodegenerative diseases as a critical regulator of …
microbiota is essential in developing neurodegenerative diseases as a critical regulator of …
[HTML][HTML] Green tea polyphenol epigallocatechin-gallate in amyloid aggregation and neurodegenerative diseases
L Fernandes, TR Cardim-Pires, D Foguel… - Frontiers in …, 2021 - frontiersin.org
The accumulation of protein aggregates in human tissues is a hallmark of more than 40
diseases called amyloidoses. In seven of these disorders, the aggregation is associated with …
diseases called amyloidoses. In seven of these disorders, the aggregation is associated with …